OCLS 13G 04.24.12

Company

Sonoma Pharmaceuticals, Inc.

Filed

April 24, 2012

Accession Number

0001535610-12-000005

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →